U.s. Venture Partners Xii-a, L.p. - Net Worth and Insider Trading
U.s. Venture Partners Xii-a, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, U.s. Venture Partners Xii-a, L.p. owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Insider Ownership Summary of U.s. Venture Partners Xii-a, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SBTX | Silverback Therapeutics Inc | 2020-12-03 | 10 percent owner |
SPRY | ARS Pharmaceuticals Inc | 2020-12-03 | 10 percent owner |
U.s. Venture Partners Xii-a, L.p. Trading Performance
U.s. Venture Partners Xii-a, L.p. Ownership Network
U.s. Venture Partners Xii-a, L.p. Owned Company Details
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
U.s. Venture Partners Xii-a, L.p. is the 10 percent owner of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
U.s. Venture Partners Xii-a, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for U.s. Venture Partners Xii-a, L.p.. You might contact U.s. Venture Partners Xii-a, L.p. via mailing address: 1460 El Camino Real, Suite 100, Menlo Park Ca 94025.